Abstract
Objective: This study was designed to determine whether outpatient treatment of pyelonephritis in pregnancy can reduce costs without compromising safety or efficacy.
Methods: Pregnant patients with uncomplicated initial episodes of acute pyelonephritis were considered for outpatient management. The outpatient treatment consisted of an initial dose of IV ceftriaxone (2 g), followed by daily outpatient IM ceftriaxone (2 g) until resolution of fever and flank tenderness, followed by a 10-day course of oral antibiotics. The study group was compared with a group requiring inpatient treatment and a historical control group meeting the criteria for outpatient management but having been treated as inpatients in the previous year.
Results: Of the 34 treated as outpatients, only 4 (12%) required hospital admission and 1 developed an upper urinary tract recurrence. None of these patients had premature delivery or any other serious complication. The historical control group (N = 29) included 1 upper urinary tract recurrence, no preterm deliveries, and 1 case of acute respiratory disease syndrome. The outpatient group required an average of 3.4 daily outpatient visits compared with 3.9 days of hospitalization for the historical control group. The inpatient group (N = 39) was significantly more likely to require hospitalization >6 days (P = 0.0004), with a trend toward more frequent upper urinary tract recurrences (6/39 vs. 1/34, P = 0.08). The cost analysis revealed a 3-fold difference between outpatient and inpatient therapy ($1,100 vs. $3,350, P < 0.001).
Conclusions: The outpatient treatment of selected patients with pyelonephritis in pregnancy as a promising approach to reducing costs warrants further investigation.
Full Text
The Full Text of this article is available as a PDF (538.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Angel J. L., O'Brien W. F., Finan M. A., Morales W. J., Lake M., Knuppel R. A. Acute pyelonephritis in pregnancy: a prospective study of oral versus intravenous antibiotic therapy. Obstet Gynecol. 1990 Jul;76(1):28–32. [PubMed] [Google Scholar]
- Baumgartner J. D., Glauser M. P. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment. Arch Intern Med. 1983 Oct;143(10):1868–1873. [PubMed] [Google Scholar]
- Bradley J. S., Ching D. K., Phillips S. E. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J. 1988 Mar;7(3):160–164. doi: 10.1097/00006454-198803000-00005. [DOI] [PubMed] [Google Scholar]
- Francioli P., Etienne J., Hoigné R., Thys J. P., Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA. 1992 Jan 8;267(2):264–267. [PubMed] [Google Scholar]
- Gilstrap L. C., 3rd, Cunningham F. G., Whalley P. J. Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol. 1981 Apr;57(4):409–413. [PubMed] [Google Scholar]
- James J., Mulhall A., de Louvois J. Ceftriaxone--clinical experience in the treatment of neonates. J Infect. 1985 Jul;11(1):25–33. doi: 10.1016/s0163-4453(85)90926-0. [DOI] [PubMed] [Google Scholar]
- Karachalios G. N., Georgiopoulos A. N., Kintziou H. Treatment of acute pyelonephritis in women with intramuscular ceftriaxone: an out-patient study. Chemotherapy. 1991;37(4):292–296. doi: 10.1159/000238870. [DOI] [PubMed] [Google Scholar]
- Lewis D. F., Towers C. V., Garite T. J., Jackson D. N., Nageotte M. P., Major C. A. Fetal gastroschisis and omphalocele: is cesarean section the best mode of delivery? Am J Obstet Gynecol. 1990 Sep;163(3):773–775. doi: 10.1016/0002-9378(90)91066-l. [DOI] [PubMed] [Google Scholar]
- Martens M. G. Pyelonephritis. Obstet Gynecol Clin North Am. 1989 Jun;16(2):305–315. [PubMed] [Google Scholar]
- Russo T. A., Cook S., Gorbach S. L. Intramuscular ceftriaxone in home parenteral therapy. Antimicrob Agents Chemother. 1988 Sep;32(9):1439–1440. doi: 10.1128/aac.32.9.1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scully B. E., Fu K. P., Neu H. C. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection. Am J Med. 1984 Oct 19;77(4C):112–116. [PubMed] [Google Scholar]